scholarly article | Q13442814 |
editorial | Q871232 |
P356 | DOI | 10.4155/FSOA-2016-0064 |
P8608 | Fatcat ID | release_5kaovaw6n5d45afsfcnazt4v2e |
P932 | PMC publication ID | 5242196 |
P698 | PubMed publication ID | 28116137 |
P2093 | author name string | Antonino Mulè | |
Ettore Minutilli | |||
P2860 | cites work | Clonal integration of a polyomavirus in human Merkel cell carcinoma | Q24657675 |
Merkel cell carcinoma: emerging biology, current approaches, and future directions | Q26864470 | ||
Mutational analysis of merkel cell carcinoma | Q27021034 | ||
PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma. | Q27853379 | ||
Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival. | Q34866209 | ||
Clinical factors associated with Merkel cell polyomavirus infection in Merkel cell carcinoma | Q34987484 | ||
Detection of Merkel cell virus and correlation with histologic presence of Merkel cell carcinoma in sentinel lymph nodes. | Q35859015 | ||
Evaluating blood levels of neuron specific enolase, chromogranin A, and circulating tumor cells as Merkel cell carcinoma biomarkers | Q36413487 | ||
Merkel cell polyomavirus: a newly discovered human virus with oncogenic potential | Q36468289 | ||
Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus | Q36498051 | ||
Distinct gene expression profiles of viral- and nonviral-associated merkel cell carcinoma revealed by transcriptome analysis | Q36684979 | ||
Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression. | Q37333908 | ||
PD-L1 expression in the Merkel cell carcinoma microenvironment: association with inflammation, Merkel cell polyomavirus and overall survival | Q37454288 | ||
Clinical utility of a circulating tumor cell assay in Merkel cell carcinoma | Q37622003 | ||
The Merkel cell polyomavirus and its involvement in Merkel cell carcinoma | Q38079598 | ||
Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline. | Q38563536 | ||
Merkel Cell Carcinoma Therapeutic Update | Q38855025 | ||
Rationale for immune-based therapies in Merkel polyomavirus-positive and -negative Merkel cell carcinomas | Q38887303 | ||
Associations between Merkel cell carcinoma and Merkel cell polyomavirus | Q41108321 | ||
Systemic Therapy for Merkel Cell Carcinoma: What's on the Horizon? | Q41458291 | ||
Cytokeratin 20-negative Merkel cell carcinoma is infrequently associated with the Merkel cell polyomavirus | Q41662872 | ||
Merkel polyomavirus-specific T cells fluctuate with merkel cell carcinoma burden and express therapeutically targetable PD-1 and Tim-3 exhaustion markers | Q42278531 | ||
Merkel cell carcinoma with divergent differentiation: histopathological and immunohistochemical study of 15 cases with PCR analysis for Merkel cell polyomavirus. | Q43777103 | ||
Detection of a novel truncating Merkel cell polyomavirus large T antigen deletion in chronic lymphocytic leukemia cells | Q43980810 | ||
Association of Merkel cell polyomavirus infection with clinicopathological differences in Merkel cell carcinoma | Q46107548 | ||
Merkel cell carcinoma--pathogenesis, clinical aspects and treatment. | Q53219035 | ||
Genetic variability and integration of Merkel cell polyomavirus in Merkel cell carcinoma | Q83462176 | ||
P433 | issue | 4 | |
P921 | main subject | Merkel cell carcinoma | Q1711744 |
Merkel cell polyomavirus | Q1921796 | ||
P304 | page(s) | FSO155 | |
P577 | publication date | 2016-11-16 | |
P1433 | published in | Future science OA | Q27726739 |
P1476 | title | Merkel cell polyomavirus and cutaneous Merkel cell carcinoma | |
P478 | volume | 2 |
Search more.